Statin therapy for primary prevention in adults aged 80+ reduced all-cause mortality and coronary morbidity, with no increased adverse events; early discontinuation lessened benefits.
Does statin therapy for primary prevention reduce all-cause mortality and coronary morbidity in adults aged 80 and older?
Statin therapy for primary prevention in adults aged 80 and older is associated with reduced mortality and coronary morbidity without increasing adverse events.
Tasa de eventos absoluta: 0% vs 0%
In patients aged ≥ 80 years, statin therapy for primary prevention was associated with reduced all-cause mortality and coronary morbidity, without increased risk of adverse events. Early discontinuation diminished these benefits.
Lavon et al. (Sat,) reported a other. Statin therapy for primary prevention in adults aged 80+ reduced all-cause mortality and coronary morbidity, with no increased adverse events; early discontinuation lessened benefits.